furazolidone has been researched along with Cholera in 23 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
Cholera: An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test the efficacy and safety of furazolidone given as a single dose for childhood cholera, a randomized double-blind placebo-controlled trial was carried out among 118 culture-positive dehydrated children with diarrhea." | 9.07 | Efficacy of a single dose of furazolidone for treatment of cholera in children. ( Butler, T; Islam, MR; Mazumdar, R; Rabbani, GH; Shahrier, M, 1991) |
| "To evaluate single doses of 400 mg of furazolidone and 1 g of tetracycline given orally to patients with diarrhea due to Vibrio cholerae, we studied 87 adults in a randomized, double-blind, placebo-controlled trial." | 9.06 | Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial. ( Alam, K; Butler, T; Islam, MR; Rabbani, GH; Shahrier, M, 1989) |
| "A controlled comparison of furazolidone and tetracycline in the treatment of cholera indicates that, in either dosage used, furazolidone reduced total stool volume by 50% and duration of diarrhoea by 40%." | 9.03 | Controlled comparison of tetracycline and furazolidone in cholera. ( Banwell, JG; Caranasos, GJ; Keimowitz, RI; Mitra, RC; Mondal, A; Pierce, NF; Thomas, J, 1968) |
| "Tetracycline continues to be an effective antimicrobial agent in the clinical control of cholera but because of its high cost, relatively short shelf-life and recent reports of increased resistance of vibrios to tetracycline in vitro, alternative antimicrobial agents have been tested." | 7.65 | Furazolidone in paediatric cholera. ( Curlin, GT; Hirschhorn, N; Huq, MI; Karchmer, AW, 1970) |
| " cholera were as follows 76% [67,84] to furazolidone, 65% [29,94] to nitrofurantoin, 55% [44,66] to nalidixic acid, 10% [2,23] to rifampicin, 4%(0, 12) to novobiocin, 4% [2,6] to norfloxacin, 3% [1,4] to ciprofloxacin, 1%(0, 3) to sparofloxacin, 0%(0, 3) to levofloxacin, 0%(0, 2) to ofloxacin, 0%(0, 0) to gatifloxacin." | 5.22 | Globally Vibrio cholera antibiotics resistance to RNA and DNA effective antibiotics: A systematic review and meta-analysis. ( Ebrahimzadeh, F; Gholami, S; Jafari-Sales, A; Rostami, A; Zadeh, FA, 2022) |
| "To test the efficacy and safety of furazolidone given as a single dose for childhood cholera, a randomized double-blind placebo-controlled trial was carried out among 118 culture-positive dehydrated children with diarrhea." | 5.07 | Efficacy of a single dose of furazolidone for treatment of cholera in children. ( Butler, T; Islam, MR; Mazumdar, R; Rabbani, GH; Shahrier, M, 1991) |
| "To evaluate single doses of 400 mg of furazolidone and 1 g of tetracycline given orally to patients with diarrhea due to Vibrio cholerae, we studied 87 adults in a randomized, double-blind, placebo-controlled trial." | 5.06 | Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial. ( Alam, K; Butler, T; Islam, MR; Rabbani, GH; Shahrier, M, 1989) |
| "A controlled comparison of furazolidone and tetracycline in the treatment of cholera indicates that, in either dosage used, furazolidone reduced total stool volume by 50% and duration of diarrhoea by 40%." | 5.03 | Controlled comparison of tetracycline and furazolidone in cholera. ( Banwell, JG; Caranasos, GJ; Keimowitz, RI; Mitra, RC; Mondal, A; Pierce, NF; Thomas, J, 1968) |
| " Furazolidone (Furoxone) has been used for 30 years for the specific and symptomatic treatment of bacterial or protozoal diarrhoea and enteritis caused by susceptible organisms." | 4.77 | The use of furoxone: a perspective. ( Hailey, FJ; Phillips, KF, 1986) |
| " cholerae especially towards ciprofloxacin may significantly influence the control strategies in future outbreaks." | 3.75 | Epidemiology & antibiograms of Vibrio cholerae isolates from a tertiary care hospital in Chandigarh, north India. ( Chander, J; Deep, A; Gupta, V; Kaistha, N; Mehta, M; Sarkar, BL; Singla, N, 2009) |
| "Tetracycline continues to be an effective antimicrobial agent in the clinical control of cholera but because of its high cost, relatively short shelf-life and recent reports of increased resistance of vibrios to tetracycline in vitro, alternative antimicrobial agents have been tested." | 3.65 | Furazolidone in paediatric cholera. ( Curlin, GT; Hirschhorn, N; Huq, MI; Karchmer, AW, 1970) |
| "cholerae were obtained from water sources used by cholera cases due to resistant V." | 1.27 | Epidemiological differences between cholera due to multiple antibiotic resistant and multiple antibiotic sensitive Vibrio cholerae infection. ( Barua, DK; Begum, T; Khan, MU; Shahidullah, M, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (65.22) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Rostami, A | 1 |
| Zadeh, FA | 1 |
| Ebrahimzadeh, F | 1 |
| Jafari-Sales, A | 1 |
| Gholami, S | 1 |
| Parvin, I | 1 |
| Shahunja, KM | 1 |
| Khan, SH | 1 |
| Alam, T | 1 |
| Shahrin, L | 1 |
| Ackhter, MM | 1 |
| Sarmin, M | 1 |
| Dash, S | 1 |
| Rahman, MW | 1 |
| Shahid, ASMSB | 1 |
| Golam Faruque, AS | 1 |
| Ahmed, T | 1 |
| Chisti, MJ | 1 |
| Kingston, JJ | 1 |
| Zachariah, K | 1 |
| Tuteja, U | 1 |
| Kumar, S | 1 |
| Batra, HV | 1 |
| Chander, J | 1 |
| Kaistha, N | 1 |
| Gupta, V | 1 |
| Mehta, M | 1 |
| Singla, N | 1 |
| Deep, A | 1 |
| Sarkar, BL | 1 |
| Rashed, SM | 1 |
| Mannan, SB | 1 |
| Johura, FT | 1 |
| Islam, MT | 1 |
| Sadique, A | 1 |
| Watanabe, H | 1 |
| Sack, RB | 1 |
| Huq, A | 1 |
| Colwell, RR | 1 |
| Cravioto, A | 1 |
| Alam, M | 1 |
| DUTTA, NK | 1 |
| PANSE, MV | 1 |
| Black, RE | 1 |
| Niyogi, SK | 2 |
| Sengupta, PG | 2 |
| Bhattacharya, SK | 2 |
| Garg, S | 1 |
| Mukhapadhayay, AK | 1 |
| Nair, GB | 1 |
| Mazumdar, DN | 1 |
| De, S | 1 |
| De, SP | 1 |
| Sircar, BK | 1 |
| Frost, WH | 1 |
| Anishchuk, VP | 1 |
| Rabbani, GH | 2 |
| Butler, T | 2 |
| Shahrier, M | 2 |
| Mazumdar, R | 1 |
| Islam, MR | 2 |
| Alam, K | 1 |
| Phillips, KF | 1 |
| Hailey, FJ | 1 |
| Khan, MU | 1 |
| Shahidullah, M | 1 |
| Barua, DK | 1 |
| Begum, T | 1 |
| Chaudhuri, RN | 1 |
| Neogy, KN | 1 |
| Sanyal, SN | 1 |
| Gupta, RK | 1 |
| Manji, P | 1 |
| Pierce, NF | 3 |
| Banwell, JG | 2 |
| Mitra, RC | 3 |
| Caranasos, GJ | 1 |
| Keimowitz, RI | 1 |
| Thomas, J | 1 |
| Mondal, A | 3 |
| Gorbach, SL | 2 |
| Carpenter, CC | 1 |
| Hirschhorn, N | 2 |
| Karchmer, AW | 1 |
| Curlin, GT | 1 |
| Huq, MI | 1 |
| Banwell, JC | 1 |
| Manji, PM | 1 |
4 reviews available for furazolidone and Cholera
| Article | Year |
|---|---|
Globally Vibrio cholera antibiotics resistance to RNA and DNA effective antibiotics: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Cephalothin; Cholera; Cholera Toxin; Ciprofloxacin; Drug Resistance, Bacteria | 2022 |
The prophylaxis and therapy of secretory diarrhea.
Topics: Anti-Infective Agents, Urinary; Antidiarrheals; Chloramphenicol; Chlorpromazine; Cholera; Diarrhea; | 1982 |
[The clinical course and treatment of cholera in children (review of the foreign literature)].
Topics: Acid-Base Equilibrium; Acute Disease; Age Factors; Bicarbonates; Body Temperature; Child; Child, Pre | 1975 |
The use of furoxone: a perspective.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Bacterial Vaccines; Carrier St | 1986 |
5 trials available for furazolidone and Cholera
| Article | Year |
|---|---|
Minocycline, tetracycline and furazolidone in the treatment of cholera.
Topics: Adult; Cholera; Furazolidone; Humans; Minocycline; Tetracycline; Tetracyclines | 1977 |
Efficacy of a single dose of furazolidone for treatment of cholera in children.
Topics: Adolescent; Child; Child, Preschool; Cholera; Double-Blind Method; Female; Furazolidone; Humans; Inf | 1991 |
Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial.
Topics: Adult; Cholera; Diarrhea; Double-Blind Method; Feces; Furazolidone; Humans; Randomized Controlled Tr | 1989 |
Furazolidone in the treatment of cholera.
Topics: Adult; Cholera; Furazolidone; Humans; Male; Tetracycline | 1968 |
Controlled comparison of tetracycline and furazolidone in cholera.
Topics: Adult; Cholera; Clinical Trials as Topic; Diarrhea; Feces; Furazolidone; Humans; Male; Middle Aged; | 1968 |
14 other studies available for furazolidone and Cholera
| Article | Year |
|---|---|
Changing Susceptibility Pattern of
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Child; Cholera; Ciprofloxacin; Drug Resistan | 2020 |
Molecular characterization of Vibrio cholerae isolates from cholera outbreaks in North India.
Topics: Anti-Bacterial Agents; Cholera; Cloxacillin; Disease Outbreaks; DNA Fingerprinting; Endopeptidases; | 2009 |
Epidemiology & antibiograms of Vibrio cholerae isolates from a tertiary care hospital in Chandigarh, north India.
Topics: Age Factors; Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Cholera; Ciprofloxacin; Drug Resistance | 2009 |
Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006-2011.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Typing Techniques; Bangladesh; Base Sequence; | 2012 |
PAROMOMYCIN, POLYMYXIN B AND FURAZOLIDONE IN EXPERIMENTAL CHOLERA.
Topics: Animals; Cholera; Furazolidone; Paromomycin; Pharmacology; Polymyxin B; Polymyxins; Rabbits; Researc | 1964 |
Emergence of furazolidone and cotrimoxazole resistant Vibrio cholerae 01 in eastern India.
Topics: Anti-Bacterial Agents; Cholera; Drug Resistance, Microbial; Furazolidone; Humans; India; Infant; Tri | 1995 |
An outbreak of Eltor cholera in Aizwal town of Mizoram, India.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Cholera; Diarrhea; Disease Outbre | 2000 |
Cholera: synopsis of clinical aspects and principles of treatment.
Topics: Adult; Bicarbonates; Child; Chloramphenicol; Cholera; Dehydration; Female; Furazolidone; Humans; Lac | 1976 |
Epidemiological differences between cholera due to multiple antibiotic resistant and multiple antibiotic sensitive Vibrio cholerae infection.
Topics: Anti-Bacterial Agents; Bangladesh; Cholera; Drug Resistance, Microbial; Furazolidone; Humans; Vibrio | 1986 |
Convalescent carriers of Vibrio cholerae. Detection and detailed investigation.
Topics: Adolescent; Adult; Age Factors; Aged; Agglutination Tests; Antibodies; Bacteriological Techniques; C | 1970 |
Pediatric cholera: current concepts of therapy.
Topics: Administration, Oral; Age Factors; Bicarbonates; Child; Child, Preschool; Chlorides; Cholera; Choler | 1972 |
Furazolidone in paediatric cholera.
Topics: Antibody Formation; Body Weight; Child; Child, Preschool; Cholera; Diarrhea; Feces; Female; Furazoli | 1970 |
Bacteriological studies of convalescent carriers of cholera vibrios.
Topics: Adult; Carrier State; Cholera; Furazolidone; Humans; Male; Tetracycline; Vibrio | 1969 |
Chemotherapy and control of cholera.
Topics: Anti-Bacterial Agents; Cholera; Furazolidone; Humans | 1966 |